Desq Long
Sign in

Company

MiNK Therapeutics, Inc.

INKT · CIK 0001840229

SEC FORM 4
$17,881.35

MiNK Therapeutics, Inc. (INKT)

Acquisition (code A) of 1,633 shares at $10.95 per share.

Reporting Person Corvese Brian · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-379513 · filed 2026-09-02 · View filing →

SEC FORM 4
$17,760.90

MiNK Therapeutics, Inc. (INKT)

Acquisition (code A) of 1,622 shares at $10.95 per share.

Reporting Person Ryan Barbara · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-379518 · filed 2026-09-02 · View filing →

SEC FORM 4
$16,260.75

MiNK Therapeutics, Inc. (INKT)

Acquisition (code A) of 1,485 shares at $10.95 per share.

Reporting Person Behner Peter · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-379522 · filed 2026-09-02 · View filing →

SEC FORM 4
$13,501.35

MiNK Therapeutics, Inc. (INKT)

Acquisition (code A) of 1,233 shares at $10.95 per share.

Reporting Person Holcomb John Bradley · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-379524 · filed 2026-09-02 · View filing →

SEC FORM 4
$14,005.05

MiNK Therapeutics, Inc. (INKT)

Acquisition (code A) of 1,279 shares at $10.95 per share.

Reporting Person WIINBERG ULF · Transaction Code A

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-379575 · filed 2026-09-02 · View filing →